The Next Generation of JAK Inhibitors: an Update on Fedratinib, Momelotonib, and Pacritinib.

Patel AA, Odenike O. The Next Generation of JAK Inhibitors: an Update on Fedratinib, Momelotonib, and Pacritinib. Curr Hematol Malig Rep. 2020 12; 15(6):409-418.

View in: PubMed

subject areas

Antineoplastic Combined Chemotherapy Protocols
Benzamides
Clinical Trials as Topic
Disease Management
Disease Progression
Disease Susceptibility
Humans
Molecular Targeted Therapy
Myeloproliferative Disorders
Pyrimidines
Pyrrolidines
Sulfonamides
Treatment Outcome

authors with profiles

Olatoyosi Odenike
Anand Patel